We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pathology

Image: Galleri Multi-Cancer Test (Photo courtesy of GRAIL, LLC)

Multi-Cancer Early Detection Test Could Become a Game-Changing Screening Tool

A first-of-kind multi-cancer early detection test can detect over 50 types of cancers with a low false positive rate through a single blood draw. More...
16 Feb 2022
Image: TriNetra-Prostate blood test (Photo courtesy of Datar Cancer Genetics)

Early-Stage Prostate Cancer Detection Blood Test Granted FDA Breakthrough Designation

A circulating tumor cell (CTC) detection blood test can identify early-stage prostate cancer with high accuracy in men of age 55-69 years. More...
16 Feb 2022
Image: Immunochemistry showing strong immunoreactivity for p53 in Barrett\'s esophagus with high-grade dysplasia (Photo courtesy of ARP Press (@ARP_Press)

Cytosponge Biomarker Panel Prioritizes Endoscopic Barrett's Esophagus Surveillance

Endoscopic surveillance is recommended for patients with Barrett's esophagus because, although the progression risk is low, endoscopic intervention is highly effective for high-grade dysplasia and cancer. However, repeated endoscopy has associated harms and access has been limited during the COVID-19 pandemic. We aimed to evaluate the role of a non-endoscopic device (Cytosponge) coupled with laboratory biomarkers and clinical factors to prioritize endoscopy for Barrett's esophagus. More...
15 Feb 2022
Image: WATS3D (Photo courtesy of CDx Diagnostics Inc.)

AI-Powered Diagnostic Platform Improves Early Detection of Esophageal Cancer in Patients with Barrett’s Esophagus

A new study will test the effectiveness of a novel diagnostic tool to improve detection of early esophageal cancer. More...
09 Feb 2022
Image: The Agilent DNA Microarray Scanner (Photo courtesy of Agilent Technologies)

Novel Urinary miRNA Biomarker for Early Detection of Colorectal Cancer

Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide. Pathological diagnosis using biopsy samples acquired during a colonoscopy (CS) is the gold standard for CRC diagnosis. More...
07 Feb 2022
Illustration

New Method Determines Optimal Number of Pathologists Needed for Correct Disease Diagnosis

A new method, named the Observers Needed for Evaluation of Subjective Tests (ONEST), has been developed to determine the optimal number of pathologists needed for a correct diagnosis. More...
07 Feb 2022
Image: The Proprium Fibro-CHI Diagnostic ELISA Kit for the quantification of Chitinase 3-Like 1 (CHI3L1) in serum and plasma (Photo courtesy of Proprium Biotech Company Limited)

Diagnostic Value of Serum CHI3L1 in Hepatocellular Carcinoma Explored

Primary liver cancer is the sixth diagnosed cancer and the fourth cause of cancer-related death worldwide. Hepatocellular carcinoma (HCC) is the major pathological category and comprises a 75%–85% incidence of primary liver cancer cases. More...
02 Feb 2022
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
ADLM